PISCATAWAY, N.J. – Camber Pharmaceuticals announced today the addition of Methylphenidate chewable tablet to its growing portfolio of products.

Methylphenidate chewable tablet is the generic version of Methylin from Mallinckrodt and is used to treat attention deficit hyperactivity disorder — ADHD. Methylphenidate chewable tablets are available in 2.5, 5 and 10mg 100 count bottles.

The company stated with introductions like this its commitment to its customers is to bring the highest quality generic pharmaceuticals to the market and provide a level of excellence in service, supply and affordability.